A

Arena Pharmaceuticals Inc
F:RN3N

Watchlist Manager
Arena Pharmaceuticals Inc
F:RN3N
Watchlist
Price: 90.5 EUR 0.56% Market Closed
Market Cap: 5.6B EUR

Wall Street
Price Targets

RN3N Price Targets Summary
Arena Pharmaceuticals Inc

There are no price targets for RN3N.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Arena Pharmaceuticals Inc Competitors:
Price Targets
TECX
AVROBIO Inc
317% Upside
MRNA
Moderna Inc
6% Upside
VLA
Valneva SE
85% Upside
300653
Yantai Zhenghai Bio-Tech Co Ltd
26% Upside
AVCT
Avacta Group PLC
31% Upside
SPRB
Spruce Biosciences Inc
171% Upside
PTCT
PTC Therapeutics Inc
5% Upside
AMRN
Amarin Corporation PLC
11% Downside

Revenue
Forecast

Revenue Estimate
Arena Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Arena Pharmaceuticals Inc's revenue is -60%. The projected CAGR for the next 1 year is 47 400%.

-60%
Past Growth
47 400%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Arena Pharmaceuticals Inc

Operating Income forecast
is not available for
Arena Pharmaceuticals Inc

Net Income
Forecast

Net Income Estimate
Arena Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RN3N's stock price target?
Not Available

RN3N doesn't have any price targets made by Wall Street professionals.

What is Arena Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
47 400%

For the last 8 years the compound annual growth rate for Arena Pharmaceuticals Inc's revenue is -60%. The projected CAGR for the next 1 year is 47 400%.

Back to Top